Patents by Inventor Nicolas Sierro

Nicolas Sierro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230318474
    Abstract: A method can be used for operating a converter that converter includes a control arrangement and modular-multilevel converters that are coupled in a parallel circuit. Each modular-multilevel converters includes branches, each having a cell with a capacitor and semiconductor switches. First voltage reference signals are generated as a function of a DC voltage reference and measured signals gained at the modular-multilevel converters and a second voltage reference signal is generated as a function of a first terminal reference. An inner voltage reference signal is generated as a function of an average DC voltage reference and of branch capacitor voltage signals. The first voltage reference signals, the second voltage reference signal and the inner voltage reference signal are combined into a branch control signal for each branch. Cell control signals are generated as a function of the branch control signals and provided to the semiconductor switches.
    Type: Application
    Filed: August 26, 2021
    Publication date: October 5, 2023
    Inventors: Michail Vasiladiotis, Nicolas Sierro
  • Patent number: 10501732
    Abstract: There is disclosed a mutant, non-naturally occurring or transgenic plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a threonine synthase and having at least 90% sequence identity to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 or at least 87% sequence identity to SEQ ID NO:4, or SEQ ID NO:5; (ii) a polypeptide encoded by any one of said polynucleotides set forth in (i); or (iii) a polypeptide having at least 95% sequence identity to SEQ ID NO:6, SEQ ID NO:7 or SEQ ID NO:8; or (iv) a construct, vector or expression vector comprising the polynucleotide as set forth in (i).
    Type: Grant
    Filed: August 31, 2012
    Date of Patent: December 10, 2019
    Assignee: Philip Morris Products S.A.
    Inventors: Lucien Bovet, Nicolas Sierro
  • Patent number: 10415050
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: September 17, 2019
    Assignee: Philip Morris Products S.A.
    Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
  • Publication number: 20170130239
    Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.
    Type: Application
    Filed: May 7, 2015
    Publication date: May 11, 2017
    Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
  • Publication number: 20150106971
    Abstract: There is disclosed a mutant, non-naturally occurring or transgenic plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a threonine synthase and having at least 90% sequence identity to SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:3 or at least 87% sequence identity to SEQ ID NO:4, or SEQ ID NO:5; (ii) a polypeptide encoded by any one of said polynucleotides set forth in (i); or (iii) a polypeptide having at least 95% sequence identity to SEQ ID NO:6, SEQ ID NO:7 or SEQ ID NO:8; or (iv) a construct, vector or expression vector comprising the polynucleotide as set forth in (i).
    Type: Application
    Filed: August 31, 2012
    Publication date: April 16, 2015
    Applicant: PHILIP MORRIS PRODUCTS S.A.
    Inventors: Lucien Bovet, Nicolas Sierro